Skip to main content

Advertisement

SpringerLink
Log in

Inhibition of lymphocyte response by prostaglandin-producing suppressor cells in patients with melanoma

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Peripheral blood mononuclear cells (PBMC) from 11 patients with metastatic melanoma (group II) had a significant decrease in blastogenesis to concanavalin A (Con A) (38.7±7.7 cpm × 103; mean ± SE) compared to 21 patients who were disease free (70.6±6.7) or 16 healthy controls (83.6±10.3). If PBMC from patients were preincubated for 72 hr prior to exposure to mitogen, blastogenesis was restored to normal. In group II patients a similar improvement in reactivity of fresh PBMC occurred with indomethacin addition or following rigorous depletion of adherent monocytes. Supernatants from cells cultured with and without Con A in several group II patients contained very high levels of endogenous PGE2. Patients had a greater percentage of T lymphocytes bearing Fc receptors for ox erythrocytes (Tγ) than controls, which appeared to correlate with the increased sensitivity to suppression by exogenously added PGE2. These data suggest that the decreased blastogenesis in certain melanoma patients is due to an increase in PGE2 production by monocytes, along with an increase in lymphocyte sensitivity to its effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Golub SH, O'Connell TX, Morton DL: Correlation of in vivo and in vitro assays of immunocompetence in cancer patients. Cancer Res 34:1833–1837, 1974

    Google Scholar 

  2. Catalona WJ, Cretien PB: Abnormalities of quantitative dinitrochlorobenzine sensitization in cancer patients: Correlations with tumor stage and histology. Cancer 31:353–356, 1973

    Google Scholar 

  3. Lichtenstein A, Zighelboim J, Dorey F, Brossman S, Fahey JL: Comparison of immune derangements in patients with different malignancies. Cancer 45:2090–2095, 1980

    Google Scholar 

  4. Glasgow AH, Nimberg RB, Menzoian JO, Saporoschetz I, Cooperband SR, Schmid K, Mannick JA: Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer. N Engl J Med 291:1263–1267, 1974

    Google Scholar 

  5. Hellstrom I, Hellstrom KE, Evans CA, Heffner GH, Pierce GE, Yang JPS: Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci USA 62:362–368, 1969

    Google Scholar 

  6. Boetcher DA, Leonard EJ: Abnormal monocyte chemotactic response in cancer patients. J Natl Cancer Inst 52:1091–1099, 1974

    Google Scholar 

  7. Hersey P, Edwards A, Honeyman M, McCarthy WH: Low natural killer cell activity in familial melanoma patients and their relatives. Br J Cancer 40:113–122, 1979

    Google Scholar 

  8. Eilber FR, Nizze JA, Morton DL: Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course. Cancer 35:660–665, 1975

    Google Scholar 

  9. Cheema AR, Hersh EM: Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis. Cancer 28:851–855, 1971

    Google Scholar 

  10. Zembala M, Mytar B, Popiela T, Asherson GL: Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients. Int J Cancer 19:605–613, 1977

    Google Scholar 

  11. Quan PC, Burtin P: Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients. Cancer Res 38:288–296, 1978

    Google Scholar 

  12. Jerrels TR, Dean JH, Richardson GL, McCoy JL, Herberman RB: Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients. J Natl Cancer Inst 61:1001–1009, 1978

    Google Scholar 

  13. Herr HW: Suppressor cells in immunodepressed bladder and prostate cancer patients. J Urol 123:635–639, 1980

    Google Scholar 

  14. Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH, Williams RC: Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med 297:963–967, 1977

    Google Scholar 

  15. Han T, Takita H: Indomethacin mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients. Cancer 46:2416–2420, 1980

    Google Scholar 

  16. DeGast GC, The TH, Koops HS, Huiges HA, Oldhoff J, Nieweg HO: Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocytic reactivity to PHA and antigens following immunization. Cancer 36:1289–1297, 1975

    Google Scholar 

  17. Stobo JD, Paul S, VanScoy RE, Hermans PE: Suppressor thymus derived lymphocytes in fungal infection. J Clin Invest 57:319–328, 1976

    Google Scholar 

  18. Whisler RL, Balcerzak SP, Murray JL: Heterogeneous mechanisms in impaired lymphocyte responses in non-Hodgkin's lymphoma. Blood 57:1081–1087, 1981

    Google Scholar 

  19. Koller CA, King GW, Hurtubise PE, Sagone AL, LoBuglio AF: Characterization of glass-adherent human mononuclear cells. J Immunol 111:1610–1612, 1973

    Google Scholar 

  20. Li CY, Lam KW, Yam LT: Esterases in human leukocytes. J Histochem Cytochem 21:1–12, 1973

    Google Scholar 

  21. Galli V, Schlesinger M: The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or sheep red blood cells. J Immunol 112:1628–1634, 1974

    Google Scholar 

  22. Gupta S, Good RA: Subpopulations of human T lymphocytes. II. Effect of thymopoeitin, corticosteroids and irradiation. Cell Immunol 34:10–18, 1977

    Google Scholar 

  23. Stahl RAK, Attallah AA, Bloch DL, Lee JB: Stimulation of rabbit renal PGE2 biosynthesis by dietary sodium restriction. Am J Physiol 237:344–349, 1979

    Google Scholar 

  24. Bresnihan B, Jason HE: Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosis. J Clin Invest 59:106–116, 1976

    Google Scholar 

  25. Goodwin JS, Messner RP, Peake GT: Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation. J Clin Invest 62:753–759, 1978

    Google Scholar 

  26. Kurland JI, Bockman R: Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med 147:952–957, 1978

    Google Scholar 

  27. Tilden AB, Balch CM: Indomethacin enhancement of immunocompetence in melanoma patients. Surgery 90:77–84, 1981

    Google Scholar 

  28. Goldyne ME, Stobo JD: Synthesis of prostaglandins by subpopulations of human peripheral blood monocytes. Prostaglandins 18:687–693, 1979

    Google Scholar 

  29. Picker LJ, Raff HV, Goldyne ME, Stobo JD: Metabolic heterogeneity among human monocytes and its modulation by PGE2. J Immunol 124:2557–2562, 1980

    Google Scholar 

  30. Maca RD, Panje WR: Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre and postirradiation therapy. Cancer 50:483–489, 1982

    Google Scholar 

  31. Gemsa D: Stimulation of prostaglandin E release from macrophages and possible role in the immune response. Lymphokines 4:355–375, 1981

    Google Scholar 

  32. Goodwin JS, Kazubowski PA, Williams RC Jr: Cyclic adenosine monophosphate. Response to prostaglandin E2 on subpopulations of human lymphocytes. J Exp Med 150:1260–1264, 1979

    Google Scholar 

  33. Stobo JD: Immunosuppression in man. Suppression by macrophages can be mediated by interactions with regulatory T cells. J Immunol 119:918–924, 1977

    Google Scholar 

  34. Stobo JD, Kennedy MS, Goldyne ME: Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T cell subpopulations. J Clin Invest 64:1188–1195, 1979

    Google Scholar 

  35. Raupp LC, Lum LG, Oppenheim JJ, Blaese RM, Olson D, Smith-Gill SJ: Enhanced cyclic AMP production by activated human Fc-IgG receptor positive T-cell subpopulations. Clin Immunol Immunopathol 21:1–11, 1981

    Google Scholar 

  36. Werkmeister J, Phillips G, McCarthy W, Hersey P: Suppressor cell activity in melanoma patients. II. Concanavalin A induced suppressor cells in relation to tumor growth and T cell subsets. Int J Cancer 28:11–15, 1981

    Google Scholar 

  37. Kazubowski PA, Goodwin JS: Monocyte-produced prostaglandin induces Fc receptor expression of human T cells. Cell Immunol 68:343–348, 1982

    Google Scholar 

  38. Friedman SA, Remold-O'Donnell E, Piessens WF: Enhanced PGE production by MAF-treated peritoneal exudate macrophages. Cell Immunol 42:213–218, 1979

    Google Scholar 

  39. Webb DR, Nowowiejski I: Control of suppressor cell activation via endogenous prostaglandin synthesis: The role of T cells and macrophages. Cell Immunol 63:321–328, 1981

    Google Scholar 

  40. Plescia OD, Smith AH, Grinwich K: Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci USA 72:1848–1851, 1975

    Google Scholar 

  41. Lynch NR, Solomon JC: Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. J Natl Cancer Inst 62:117–120, 1979

    Google Scholar 

  42. Kollmorgen GM, Sansing WA, Lehman AA, Fischer G, Longley RE, Alexander SS Jr, King MM, McCay PB: Inhibition of lymphocyte function in rats fed high-fat diets. Cancer Res 39:3458–3462, 1979

    Google Scholar 

  43. Kollmorgen GM, Longley RE, Kosanke SD, Carpenter MP, Loh PT: Dietary fat stimulates mammary tumor growth and inhibits immune responses.In Modulation and Mediation of Cancer by Vitamins, F Meyskens, K Prasad (eds). Basel, Karger (in press)

  44. Goodwin JS, Bankhurst AD, Murphy SA,et al.: Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin. J Clin Lab Immunol 1:197–199, 1978

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Program, Oklahoma Medical Research Foundation, and Department of Medicine, Oklahoma University Health Sciences Center, 73104, Oklahoma City, Oklahoma

    J. Lee Murray

  2. Cancer Research Program, Oklahoma Medical Research Foundation, and Department of Radiological Sciences, Oklahoma University Health Sciences Center, 73104, Oklahoma City, Oklahoma

    G. Mark Kollmorgen

Authors
  1. J. Lee Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Mark Kollmorgen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murray, J.L., Kollmorgen, G.M. Inhibition of lymphocyte response by prostaglandin-producing suppressor cells in patients with melanoma. J Clin Immunol 3, 268–276 (1983). https://doi.org/10.1007/BF00915351

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00915351

Key words

Search

Navigation